#novonordisk Trending Posts - CTPtalk

3 months ago

Novo Nordisk Scores First FDA Approval for an Oral GLP-1 Drug for Obesity On December 22, 2025 , the U.S. Food and Drug Administration officially approved the once-daily oral version of Wegovy (semaglutide 25 mg) as the **first ever

58

0

89.256 CTP